The popularity of Viagra initially drove a surge for the drug industry, but recent changes present a murky outlook for shareholders. Off-patent alternatives are reducing earnings, and ongoing legal battles add further https://umarzolf160386.elbloglibre.com/41557238/the-blue-pill-and-pharma-a-volatile-bet